Guidance for ACADIA Pharmaceuticals (ACAD)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
2023 | N/A | N/A | $520.00M – 530.00M | $569.00M | = Maintained | Details |
2023 | N/A | N/A | $530.00M – 545.00M | $652.10M | = Maintained | Details |
2022 | N/A | N/A | $510.00M – 560.00M | $540.70M | = Maintained | Details |
2022 | N/A | N/A | $510.00M – 540.00M | $531.00M | = Maintained | Details |
Q3 2021 | N/A | N/A | $480.00M – 515.00M | $527.70M | = Maintained | Details |
2020 | N/A | N/A | $440.00M – 470.00M | N/A | = Maintained | Details |
2019 | N/A | N/A | $275.00M – 300.00M | $297.15M | = Maintained | Details |
2019 | N/A | N/A | $280.00M – 300.00M | $291.20M | = Maintained | Details |
2019 | N/A | N/A | $320.00M – 330.00M | $292.80M | Raised | Details |
Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
2017 | N/A | N/A | $105.00M – 115.00M | N/A | = Maintained | Details |
2017 | N/A | N/A | $124.00M – 127.00M | N/A | = Maintained | Details |
Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |